Delivery Order SPE2DB24D3015-SPE2DB25FFYMU
Award Date
3/17/25
Potential Completion Date
3/18/25
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,824.64, is a firm fixed-price delivery order for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a medical product. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,207.62 Firm Fixed Price delivery order is for the supply of Pulmozyme 1 mg/ml ampuls (2.5 ml). The contract has an ultimate completion date of August 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,244.38 firm fixed-price delivery order covers the supply of Pulmozyme 1 mg/ml ampules, a specialty medication, with a completion date of December 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,535.06 firm fixed-price delivery order is for the supply of Pulmozyme, a 1 mg/ml ampul medication. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pulmozyme 1 mg/ml ampul 2.5 ml. The $30,161.60 firm fixed-price contract has a completion date of May 25, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml. The contract is a Delivery Order with a Firm Fixed Price of $25,335.45 and a period of performance through November 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,410.94, is a delivery order for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a specialized pharmaceutical product. The contract has an ultimate completion date of April 30, 2024 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,810.96 firm-fixed-price delivery order provides Pulmozyme 1 mg/ml ampul 2.5ml, a medication used in the treatment of cystic fibrosis. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,849.28, is for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract has a firm fixed price and is a delivery order, with a period of performance through November 29, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $16,730.01 and an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself...